当前位置: X-MOL 学术N. Engl. J. Med. › 论文详情
Triple Therapy for Cystic Fibrosis with a Phe508del CFTR Mutation
The New England Journal of Medicine ( IF 70.670 ) Pub Date : 2020-02-13 , DOI: 10.1056/nejmc1916747


This article has no abstract; the first 100 words appear below. To the Editor: In the article by Middleton et al. (Nov. 7 issue),1 I did not find a description of the race or ethnic background of the patients. Since minorities make up an appreciable and increasing percentage of patients with cystic fibrosis and have a greater burden from the disease, with higher mortality and more severe pulmonary disease than nonminorities, it would be of value to know the race and ethnic group of the patients enrolled in this trial.2-4 If there are too few minorities to draw any valid conclusions from the available data, is there a plan to enroll . . .
更新日期:2020-02-13

 

全部期刊列表>>
Springer Nature 2019高下载量文章和章节
化学/材料学中国作者研究精选
《科学报告》最新环境科学研究
ACS材料视界
自然科研论文编辑服务
中南大学国家杰青杨华明
南开大学陈弓课题组招聘启事
中南大学
材料化学和生物传感方向博士后招聘
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug